Kancera: Positive pre-IND feedback from the FDA
5 juni, 09:49
5 juni, 09:49
Redeye comments on this morning’s news that Kancera has received positive feedback on the planned clinical program for KAND567 in ST-elevation myocardial infarction.
5 juni, 09:49
Redeye comments on this morning’s news that Kancera has received positive feedback on the planned clinical program for KAND567 in ST-elevation myocardial infarction.
Aktierekommendationer
Oljepriset
Aktierekommendationer
Oljepriset
1 DAG %
Senast
Swedbank Robur Global Emerging Markets A
Igår, 15:13
Förvaltaren gör comeback i Japanfonden – Barnevik lämnar
VEF
Igår, 14:01
VEF: Det hänger på Creditas
OMX Stockholm 30
1 DAG %
Senast
2 452,44